Cargando…

A metabolomic study of the PPARδ agonist GW501516 for enhancing running endurance in Kunming mice

Exercise can increase peroxisome proliferator-activated receptor-δ (PPARδ) expression in skeletal muscle. PPARδ regulates muscle metabolism and reprograms muscle fibre types to enhance running endurance. This study utilized metabolomic profiling to examine the effects of GW501516, a PPARδ agonist, o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei, Gao, Rong, Xie, Xinni, Zheng, Zhibing, Li, Haijing, Li, Song, Dong, Fangting, Wang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421799/ https://www.ncbi.nlm.nih.gov/pubmed/25943561 http://dx.doi.org/10.1038/srep09884

Ejemplares similares

The Role of PPARδ Agosnist GW501516 in Rats with Gestational Diabetes Mellitus
por: Zhou, Jun, et al.
Publicado: (2020)

PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis
por: Ji, Yangyang, et al.
Publicado: (2018)

PPARδ Agonist GW501516 Inhibits PDGF-Stimulated Pulmonary Arterial Smooth Muscle Cell Function Related to Pathological Vascular Remodeling
por: Liu, Guangjie, et al.
Publicado: (2013)

PPARδ Agonist GW501516 Suppresses the TGF-β-Induced Profibrotic Response of Human Bronchial Fibroblasts from Asthmatic Patients
por: Paw, Milena, et al.
Publicado: (2023)

Effects of the PPAR-β agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination
por: Defaux, Antoinette, et al.
Publicado: (2009)

The PPARδ Ligand GW501516 Reduces Growth but Not Apoptosis in Mouse Inner Medullary Collecting Duct Cells
por: Clark, Jordan, et al.
Publicado: (2009)

The PPARδ Agonist GW501516 Improves Lipolytic/Lipogenic Balance through CPT1 and PEPCK during the Development of Pre-Implantation Bovine Embryos
por: Idrees, Muhammad, et al.
Publicado: (2019)

GW501516, a PPAR-BETA/DELTA agonist, improves inflammatory pathways in the kidney of high-fructose fed mice
por: Magliano, D'Angelo Carlo, et al.
Publicado: (2015)

GW501516, a PPARδ Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NFκB Pathway in Mice
por: Yang, Xu, et al.
Publicado: (2011)

PPARβ/δ Agonist GW501516 Inhibits Tumorigenesis and Promotes Apoptosis of the Undifferentiated Nasopharyngeal Carcinoma C666-1 Cells by Regulating miR-206
por: Gu, Linglan, et al.
Publicado: (2019)

GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
por: Kostadinova, Radina, et al.
Publicado: (2012)

PPARβ/δ Agonism with GW501516 Increases Myotube PGC-1α Content and Reduces BCAA Media Content Independent of Changes in BCAA Catabolic Enzyme Expression
por: Rivera, Caroline N., et al.
Publicado: (2023)

Effects of the PPAR-β/δ agonist GW0742 during resuscitated porcine septic shock
por: Wepler, Martin, et al.
Publicado: (2013)

Regulation of Muscle Fiber Type and Running Endurance by PPARδ
por: Wang, Yong-Xu, et al.
Publicado: (2004)

Correction: Regulation of Muscle Fiber Type and Running Endurance by PPARδ
Publicado: (2005)

Therapeutic potential of GW501516 and the role of Peroxisome proliferator-activated receptor β/δ and B-cell lymphoma 6 in inflammatory signaling in human pancreatic cancer cells
por: Smith, Russell W., et al.
Publicado: (2016)

Development of PPAR-agonist GW0742 as antidiabetic drug: study in animals
por: Niu, Ho-Shan, et al.
Publicado: (2015)

Context-dependent regulation of endothelial cell metabolism: differential effects of the PPARβ/δ agonist GW0742 and VEGF-A
por: Faulkner, Ashton, et al.
Publicado: (2020)

Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure
por: Elie-Caille, Céline, et al.
Publicado: (2020)

PPAR-γ Agonist GW1929 But Not Antagonist GW9662 Reduces TBBPA-Induced Neurotoxicity in Primary Neocortical Cells
por: Wojtowicz, Anna K., et al.
Publicado: (2013)

The PPARβ/δAgonist GW0742 Relaxes Pulmonary Vessels and Limits Right Heart Hypertrophy in Rats with Hypoxia-Induced Pulmonary Hypertension
por: Harrington, Louise S., et al.
Publicado: (2010)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
por: Xie, Xinni, et al.
Publicado: (2017)

PPAR-γ Agonist GW1929 Targeted to Macrophages with Dendrimer–Graphene Nanostars Reduces Liver Fibrosis and Inflammation
por: Moreno-Lanceta, Alazne, et al.
Publicado: (2023)

Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway
por: Feng, Xiaoli, et al.
Publicado: (2011)

Reduced expression of PPAR-β/δ limits the potential beneficial effects of GW0742 during septic shock in atherosclerotic swine
por: Bracht, H, et al.
Publicado: (2012)

Importance of the Proximity and Orientation of Ligand-Linkage to the Design of Cinnamate-GW9662 Hybrid Compounds as Covalent PPARγ Agonists
por: Utsugi, Yuki, et al.
Publicado: (2019)

Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6
por: Altieri, Paola, et al.
Publicado: (2012)

Novel PPAR Pan Agonist, ZBH Ameliorates Hyperlipidemia and Insulin Resistance in High Fat Diet Induced Hyperlipidemic Hamster
por: Chen, Wei, et al.
Publicado: (2014)

PPAR-δ agonist affects adipo-chondrogenic differentiation of human mesenchymal stem cells through the expression of PPAR-γ
por: Kim, Dong Hyun, et al.
Publicado: (2020)

Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats
por: Wang, Jie-ping, et al.
Publicado: (2022)

GPR120 Agonist GW9508 Ameliorated Cellular Senescence Induced by ox-LDL
por: Liu, Ruijie, et al.
Publicado: (2020)

Increase in muscle endurance in mice by dietary Yamabushitake mushroom (Hericium erinaceus) possibly via activation of PPARδ
por: Komiya, Yusuke, et al.
Publicado: (2019)

NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
por: Mackenzie, Gerardo G., et al.
Publicado: (2008)

Monitoring and evaluation of the immune status of female Kunming mice maintained in different biosafety level laboratories
por: Guo, Lei, et al.
Publicado: (2018)

Peroxisome Proliferator-Activated Receptor Delta Agonist (PPAR- δ) and Selective Androgen Receptor Modulator (SARM) Abuse: Clinical, Analytical and Biological Data in a Case Involving a Poisonous Combination of GW1516 (Cardarine) and MK2866 (Ostarine)
por: Kintz, Pascal, et al.
Publicado: (2021)

Identification of novel multitargeted PPARα/γ/δ pan agonists by core hopping of rosiglitazone
por: Wang, Xue-Jiao, et al.
Publicado: (2014)

GW Stewart
por: Kilmer, Misha E, et al.
Publicado: (2010)

PPAR-δ in Vascular Pathophysiology
por: Wang, Nanping
Publicado: (2008)

FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer
por: Lu, Lu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_29i3na9e74kf04auctus0dcsmt